Should You Add Apellis Pharmaceuticals Inc (APLS) Stock to Your Portfolio Thursday?

Apellis Pharmaceuticals Inc (APLS) is around the top of the Healthcare sector according to InvestorsObserver. APLS received an overall rating of 81, which means that it scores higher than 81% of stocks. Additionally, Apellis Pharmaceuticals Inc scored a 73 in the Healthcare sector, ranking it higher than 73% of stocks in that sector.

APLS has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on APLS!

See Full APLS Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Apellis Pharmaceuticals Inc Stock Today?

Apellis Pharmaceuticals Inc (APLS) stock is trading at $47.43 as of 2:45 PM on Thursday, Jan 5, a drop of -$2.65, or -5.29% from the previous closing price of $50.08. The stock has traded between $44.92 and $49.36 so far today. Volume today is 1,056,335 compared to average volume of 999,467. Click Here to get the full Stock Report for Apellis Pharmaceuticals Inc stock.